Bottneuro aims to become a leading provider of diagnosis and personalized neuromodulation therapies for early stage patients suffering from Alzheimer’s disease.
Bottneuro aims to become a leading provider of diagnosis and personalized neuromodulation therapies for early stage patients suffering from Alzheimer’s disease.